| Status | Study |
| Active, not recruiting |
Study Name: UV Sensor in Patients With Actinic Keratosis Condition: Keratosis, Actinic Date: 2022-06-22 Interventions: Device: UV sensorUse of UV sensor to be informed about the sun exposure daily through a mobile application |
| Recruiting |
Study Name: Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses Condition: Actinic Keratosis Date: 2016-10-31 Interventions: Drug: GDC 695 GDC 695 is a top |
| Completed |
Study Name: Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015% Condition: Actinic Keratosis Date: 2015-05-12 Interventions: Drug: Inggenol Mebutate 0.015% |
| Completed |
Study Name: Treatment of Actinic Keratoses (AK) on the Face Condition: Actinic Keratoses Date: 2015-04-03 Interventions: Drug: ingenol mebutate 0.015% |
| Completed |
Study Name: Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients Condition: Actinic Keratosis Date: 2015-01-23 Interventions: Drug: Investigational Treatment |
| Recruiting |
Study Name: IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis Condition: Keratosis, Actinic Date: 2014-10-28 Interventions: Drug: Imiquimod three times a |
| Completed |
Study Name: Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + ALA Photodynamic Therapy Condition: Actinic Keratosis Date: 2014-09-10 Interventions: Drug: Aminolevulinic Acid 20% |
| Completed |
Study Name: Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities Condition: Actinic Keratosis Date: 2014-05-07 Interventions: Drug: Aminolevulinic Acid (ALA) |
| Completed |
Study Name: Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks Condition: Actinic Keratosis Date: 2014-03-12 Interventions: Drug: Ingenol Mebutate No intervention: observation of routine use of Picato® |
| Completed |
Study Name: A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities Condition: Actinic Keratosis Date: 2013-02-06 Interventions: Drug: Ingenol mebutate gel 0.05 % |